ROIV
Roivant Sciences Ltd.Company with tickers: ROIV
CIK
1635088
CUSIP
G76279101
Shares Outstanding
719,270,385
Website
https://roivant.com
13F Activity (30d)
8 filings
6 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,500,000,000
as of 2025-06-30
Remaining Authorization
$890,300,000
as of 2026-03-31
Program Utilization
40.6%
$609,700,000 used of $1,500,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 YTD | $208,293,000 | 10-Q, filed 2026-02-06 | ||
| 2025-03-31 | $1,293,232,000 | 10-K, filed 2025-05-29 | ||